搜索





搜索





市场行情
/
股票
/
arqt
/

Arcutis Biotherapeutics Inc

ARQT

添加自选

26.860USD

-1.130-4.04%

收盘 07-31 16:00（美东）报价延迟15分钟

3.36B总市值

亏损市盈率 TTM

Arcutis Biotherapeutics Inc

26.860

-1.130-4.04%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

ARQT 利润表

您可以在这里找到Arcutis Biotherapeutics Inc的年度或季度收入报告，以深入了解Arcutis Biotherapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

营业总收入

60.07%105.40M

81.48%129.50M

121.69%99.22M

164.13%81.50M

32.84%65.85M

427.58%71.36M

17.44%44.76M

494.57%30.86M

1682.42%49.57M

356.81%13.53M

5156.41%38.11M

--5.19M

--2.78M

--2.96M

--725.00K

----

营业收入

65.08%105.40M

83.83%127.50M

121.69%99.22M

164.13%81.50M

196.01%63.85M

412.79%69.36M

451.92%44.76M

546.92%30.86M

675.58%21.57M

356.81%13.53M

1018.48%8.11M

--4.77M

--2.78M

--2.96M

--725.00K

----

主营业务成本

10.80%9.78M

69.27%11.69M

57.82%8.69M

116.28%7.49M

171.19%8.83M

207.44%6.91M

365.57%5.50M

346.39%3.46M

315.84%3.26M

363.09%2.25M

339.41%1.18M

--776.00K

--783.00K

--485.00K

--269.00K

----

营业费用

26.68%114.49M

40.67%111.12M

8.20%90.69M

18.76%96.11M

11.31%90.38M

5.75%78.99M

11.74%83.82M

12.48%80.94M

2.71%81.19M

4.64%74.69M

-28.88%75.01M

9.31%71.95M

26.22%79.05M

0.14%71.39M

84.79%105.47M

56.43%65.83M

73.56%62.63M

109.27%71.29M

49.02%57.08M

18.11%42.08M

25.95%36.09M

162.15%34.06M

161.47%38.30M

317.32%35.63M

312.13%28.65M

118.28%12.99M

90.37%14.65M

--8.54M

--6.95M

--5.95M

--7.70M

研发费用

74.58%30.63M

41.24%20.45M

0.53%19.60M

0.80%19.45M

-24.19%17.54M

-39.10%14.48M

-25.67%19.50M

-23.48%19.30M

-34.53%23.14M

-29.82%23.77M

-62.38%26.24M

-33.99%25.22M

-12.99%35.34M

-35.54%33.88M

71.73%69.73M

24.18%38.20M

87.80%40.62M

92.00%52.56M

24.01%40.60M

2.52%30.77M

-14.10%21.63M

154.48%27.37M

165.15%32.74M

316.04%30.01M

305.96%25.18M

101.18%10.76M

74.40%12.35M

--7.21M

--6.20M

--5.35M

--7.08M

折旧摊销及损耗

-82.06%562.00K

22.93%563.00K

-60.75%562.00K

60.40%563.00K

774.86%3.13M

10.63%458.00K

269.07%1.43M

-9.07%351.00K

-1.38%358.00K

19.31%414.00K

37.59%388.00K

149.03%386.00K

142.00%363.00K

155.15%347.00K

143.10%282.00K

49.04%155.00K

53.06%150.00K

288.57%136.00K

286.67%116.00K

246.67%104.00K

262.96%98.00K

45.83%35.00K

-31.82%30.00K

--30.00K

440.00%27.00K

--24.00K

--44.00K

----

--5.00K

----

营业利润

62.95%-9.09M

340.92%18.39M

121.82%8.53M

70.82%-14.61M

22.43%-24.53M

87.52%-7.63M

-5.86%-39.07M

24.99%-50.08M

58.54%-31.62M

10.60%-61.17M

64.77%-36.90M

-1.42%-66.76M

-21.77%-76.27M

4.01%-68.42M

-83.52%-104.75M

-56.43%-65.83M

-73.56%-62.63M

-109.27%-71.29M

-49.02%-57.08M

-18.11%-42.08M

-25.95%-36.09M

-162.15%-34.06M

-161.47%-38.30M

-317.32%-35.63M

-312.13%-28.65M

-118.28%-12.99M

-90.37%-14.65M

---8.54M

---6.95M

---5.95M

---7.70M

净非营业利息收入（费用）

利息收入

--2.27M

--8.90M

----

利息费用

46.48%4.37M

-45.94%3.00M

-53.84%3.07M

-59.53%3.03M

-60.13%2.98M

-28.48%5.55M

-11.99%6.65M

1.84%7.48M

6.22%7.48M

12.25%7.76M

54.30%7.56M

267.45%7.35M

283.13%7.04M

--6.92M

--4.90M

--2.00M

--1.84M

----

其他非经营性收入（费用）

-100.73%-20.00K

-336.13%-6.42M

-51.34%2.04M

-59.92%2.10M

-32.49%2.73M

1.72%2.72M

53.69%4.18M

67.54%5.23M

26.10%4.04M

-19.52%2.67M

40.40%2.72M

641.33%3.12M

2158.45%3.21M

8400.00%3.32M

1877.55%1.94M

484.72%421.00K

230.23%142.00K

-366.67%-40.00K

-1.01%98.00K

-66.51%72.00K

-93.26%43.00K

-96.48%15.00K

-41.07%99.00K

-13.31%215.00K

117.01%638.00K

21.02%426.00K

740.00%168.00K

--248.00K

--294.00K

--352.00K

--20.00K

税前利润

54.80%-11.20M

270.71%17.86M

118.03%7.49M

70.30%-15.54M

29.31%-24.78M

84.21%-10.46M

0.49%-41.54M

26.28%-52.33M

56.23%-35.06M

8.00%-66.26M

61.25%-41.74M

-5.32%-70.99M

-24.53%-80.10M

-0.97%-72.02M

-89.03%-107.71M

-60.46%-67.41M

-78.47%-64.32M

-109.48%-71.33M

-49.15%-56.98M

-18.63%-42.01M

-28.66%-36.04M

-170.92%-34.05M

-163.82%-38.20M

-327.22%-35.41M

-320.74%-28.01M

-124.39%-12.57M

-88.68%-14.48M

---8.29M

---6.66M

---5.60M

---7.67M

所得税

-66.67%93.00K

45.51%470.00K

--80.00K

--342.00K

-13.89%279.00K

1192.00%323.00K

-100.00%0.00

--0.00

--324.00K

--25.00K

--3.02M

----

除税后利润

54.93%-11.29M

261.24%17.39M

117.84%7.41M

69.64%-15.89M

29.17%-25.06M

83.72%-10.79M

7.21%-41.54M

26.28%-52.33M

55.83%-35.38M

7.96%-66.28M

58.44%-44.77M

-5.32%-70.99M

-24.53%-80.10M

-0.97%-72.02M

-89.03%-107.71M

-60.46%-67.41M

-78.47%-64.32M

-109.48%-71.33M

-49.15%-56.98M

-18.63%-42.01M

-28.66%-36.04M

-170.92%-34.05M

-163.82%-38.20M

-327.22%-35.41M

-320.74%-28.01M

-124.39%-12.57M

-88.68%-14.48M

---8.29M

---6.66M

---5.60M

---7.67M

持续经营利润

54.93%-11.29M

261.24%17.39M

117.84%7.41M

69.64%-15.89M

29.17%-25.06M

83.72%-10.79M

7.21%-41.54M

26.28%-52.33M

55.83%-35.38M

7.96%-66.28M

58.44%-44.77M

-5.32%-70.99M

-24.53%-80.10M

-0.97%-72.02M

-89.03%-107.71M

-60.46%-67.41M

-78.47%-64.32M

-109.48%-71.33M

-49.15%-56.98M

-18.63%-42.01M

-28.66%-36.04M

-170.92%-34.05M

-163.82%-38.20M

-327.22%-35.41M

-320.74%-28.01M

-124.39%-12.57M

-88.68%-14.48M

---8.29M

---6.66M

---5.60M

---7.67M

归属于母公司的净利润

54.93%-11.29M

261.24%17.39M

117.84%7.41M

69.64%-15.89M

29.17%-25.06M

83.72%-10.79M

7.21%-41.54M

26.28%-52.33M

55.83%-35.38M

7.96%-66.28M

58.44%-44.77M

-5.32%-70.99M

-24.53%-80.10M

-0.97%-72.02M

-89.03%-107.71M

-60.46%-67.41M

-78.47%-64.32M

-109.48%-71.33M

-49.15%-56.98M

-18.63%-42.01M

-28.66%-36.04M

-170.92%-34.05M

-163.82%-38.20M

-327.22%-35.41M

-320.74%-28.01M

-124.39%-12.57M

-88.68%-14.48M

---8.29M

---6.66M

---5.60M

---7.67M

归属于普通股东的净利润

54.93%-11.29M

261.24%17.39M

117.84%7.41M

69.64%-15.89M

29.17%-25.06M

83.72%-10.79M

7.21%-41.54M

26.28%-52.33M

55.83%-35.38M

7.96%-66.28M

58.44%-44.77M

-5.32%-70.99M

-24.53%-80.10M

-0.97%-72.02M

-89.03%-107.71M

-60.46%-67.41M

-78.47%-64.32M

-109.48%-71.33M

-49.15%-56.98M

-18.63%-42.01M

-28.66%-36.04M

-170.92%-34.05M

-163.82%-38.20M

-327.22%-35.41M

-320.74%-28.01M

-124.39%-12.57M

-88.68%-14.48M

---8.29M

---6.66M

---5.60M

---7.67M

基本每股收益

56.09%-0.09

257.08%0.14

117.37%0.06

70.48%-0.13

37.60%-0.20

87.91%-0.09

53.92%-0.33

63.33%-0.42

75.67%-0.32

39.48%-0.71

61.56%-0.73

11.84%-1.16

-2.83%-1.31

16.94%-1.18

-65.87%-1.89

-56.02%-1.31

-67.05%-1.27

-79.52%-1.42

-12.38%-1.14

10.82%-0.84

33.99%-0.76

-130.60%-0.79

-155.98%-1.01

-316.30%-0.94

-535.31%-1.15

-124.39%-0.34

-88.68%-0.40

---0.23

---0.18

---0.15

---0.21

稀释每股收益

56.09%-0.09

257.08%0.14

116.69%0.06

70.48%-0.13

37.60%-0.20

87.91%-0.09

53.92%-0.33

63.33%-0.42

75.67%-0.32

39.48%-0.71

61.56%-0.73

11.84%-1.16

-2.83%-1.31

16.94%-1.18

-65.87%-1.89

-56.02%-1.31

-67.05%-1.27

-79.52%-1.42

-12.38%-1.14

10.82%-0.84

33.99%-0.76

-130.60%-0.79

-155.98%-1.01

-316.30%-0.94

-535.31%-1.15

-124.39%-0.34

-88.68%-0.40

---0.23

---0.18

---0.15

---0.21

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Arcutis Biotherapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 ARQT 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Arcutis Biotherapeutics Inc 财年末的营收是多少？



Arcutis Biotherapeutics Inc 2025 财年营收为 376.07M，高于上一财年的196.54M。

Arcutis Biotherapeutics Inc 最近一个季度的营收是多少？



Arcutis Biotherapeutics Inc 最近一个季度的营收为 105.40M，同比增长 60.07%。

Arcutis Biotherapeutics Inc 全年的净利润是多少？



Arcutis Biotherapeutics Inc 2025 财年净利润为 -16.14M。

Arcutis Biotherapeutics Inc 上一季度的净利润是多少？



Arcutis Biotherapeutics Inc 最近一个季度的净利润为 -11.29M。

Arcutis Biotherapeutics Inc 年度营业利润是多少？



Arcutis Biotherapeutics Inc 2025 财年的营业利润为 -12.23M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。